Cargando…

The serotonergic system and cognitive function

Symptoms of cognitive dysfunction like memory loss, poor concentration, impaired learning and executive functions are characteristic features of both schizophrenia and Alzheimer’s disease (AD). The neurobiological mechanisms underlying cognition in healthy subjects and neuropsychiatric patients are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Švob Štrac, Dubravka, Pivac, Nela, Mück-Šeler, Dorotea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017596/ https://www.ncbi.nlm.nih.gov/pubmed/28123820 http://dx.doi.org/10.1515/tnsci-2016-0007

Ejemplares similares

The involvement of noradrenergic mechanisms in the suppressive effects of diazepam on the hypothalamic-pituitary-adrenal axis activity in female rats
por: Švob Štrac, Dubravka, et al.
Publicado: (2012)

The GABA(A) receptor α2 subunit gene (GABRA2) is associated with alcohol-related behavior
por: Švob Štrac, Dubravka, et al.
Publicado: (2012)

Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease
por: Babić, Mirjana, et al.
Publicado: (2014)

HTR1A, HTR1B, HTR2A, HTR2C and HTR6 Gene Polymorphisms and Extrapyramidal Side Effects in Haloperidol-Treated Patients with Schizophrenia
por: Grubor, Mirko, et al.
Publicado: (2020)

Theranostic Biomarkers for Schizophrenia
por: Nikolac Perkovic, Matea, et al.
Publicado: (2017)

Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases
por: Di Giovanni, Giuseppe, et al.
Publicado: (2016)

Association between reduced brain-derived neurotrophic factor concentration & coronary heart disease
por: Sustar, Aleksandra, et al.
Publicado: (2019)

Epigenetics of Alzheimer’s Disease
por: Nikolac Perkovic, Matea, et al.
Publicado: (2021)

Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs
por: Svob Strac, Dubravka, et al.
Publicado: (2016)

Short overview on metabolomic approach and redox changes in psychiatric disorders
por: Nedic Erjavec, Gordana, et al.
Publicado: (2017)

The association between HTR1B gene rs13212041 polymorphism and onset of alcohol abuse
por: Svob Strac, Dubravka, et al.
Publicado: (2019)

Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview
por: Svob Strac, Dubravka, et al.
Publicado: (2021)

Relationships of Cerebrospinal Fluid Alzheimer’s Disease Biomarkers and COMT, DBH, and MAOB Single Nucleotide Polymorphisms
por: Babić Leko, Mirjana, et al.
Publicado: (2020)

Relationship between Brain-Derived Neurotrophic Factor and Cognitive Decline in Patients with Mild Cognitive Impairment and Dementia
por: Nikolac Perkovic, Matea, et al.
Publicado: (2023)

SLC6A3, HTR2C and HTR6 Gene Polymorphisms and the Risk of Haloperidol-Induced Parkinsonism
por: Nedic Erjavec, Gordana, et al.
Publicado: (2022)

N-glycomic Profile in Combat Related Post-Traumatic Stress Disorder
por: Tudor, Lucija, et al.
Publicado: (2019)

Genetic and Epigenetic Association of Hepatocyte Nuclear Factor-1α with Glycosylation in Post-Traumatic Stress Disorder
por: Tudor, Lucija, et al.
Publicado: (2022)

The Association of the Polymorphisms in the FUT8-Related Locus with the Plasma Glycosylation in Post-Traumatic Stress Disorder
por: Tudor, Lucija, et al.
Publicado: (2023)

Catechol-O-methyltransferase rs4680 and rs4818 haplotype association with treatment response to olanzapine in patients with schizophrenia
por: Nikolac Perkovic, Matea, et al.
Publicado: (2020)

Detention in Juvenile Correctional Facilities Is Associated with Higher Platelet Monoamine Oxidase B Activity in Males
por: Podobnik, Josip, et al.
Publicado: (2020)

New tools for neuroenhancement – what about neuroethics?
por: Erhardt, Julija, et al.
Publicado: (2016)

Genetic Variants of the Brain-Derived Neurotrophic Factor and Metabolic Indices in Veterans With Posttraumatic Stress Disorder
por: Tudor, Lucija, et al.
Publicado: (2018)

Moderating Effects of BDNF Genetic Variants and Smoking on Cognition in PTSD Veterans
por: Nedic Erjavec, Gordana, et al.
Publicado: (2021)

The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy
por: Radosavljevic, Milica, et al.
Publicado: (2023)

Reduced Platelet MAO-B Activity Is Associated with Psychotic, Positive, and Depressive Symptoms in PTSD
por: Repovecki, Senka, et al.
Publicado: (2022)

Genotypic and Haplotypic Association of Catechol-O-Methyltransferase rs4680 and rs4818 Gene Polymorphisms with Particular Clinical Symptoms in Schizophrenia
por: Sagud, Marina, et al.
Publicado: (2023)

Plasma Brain-Derived Neurotrophic Factor (BDNF) Concentration and BDNF/TrkB Gene Polymorphisms in Croatian Adults with Asthma
por: Sreter, Katherina B., et al.
Publicado: (2020)

Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms
por: Vuic, Barbara, et al.
Publicado: (2023)

Haplotypic and Genotypic Association of Catechol-O-Methyltransferase rs4680 and rs4818 Polymorphisms and Treatment Resistance in Schizophrenia
por: Sagud, Marina, et al.
Publicado: (2018)

Effects of acute and chronic administration of neurosteroid dehydroepiandrosterone sulfate on neuronal excitability in mice
por: Svob Strac, Dubravka, et al.
Publicado: (2016)

Serotonin Receptor Gene Polymorphisms Are Associated with Cerebrospinal Fluid, Genetic, and Neuropsychological Biomarkers of Alzheimer’s Disease
por: Babić Leko, Mirjana, et al.
Publicado: (2022)

Platelet Serotonin (5-HT) Concentration, Platelet Monoamine Oxidase B (MAO-B) Activity and HTR2A, HTR2C, and MAOB Gene Polymorphisms in Asthma
por: Konjevod, Marcela, et al.
Publicado: (2023)

Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
por: Vuic, Barbara, et al.
Publicado: (2022)

The role of the serotonergic system in suicidal behavior
por: Sadkowski, Marta, et al.
Publicado: (2013)

The serotonergic system in migraine
por: Leone, Massimo, et al.
Publicado: (2001)

Involvement of Serotonergic System in Oxaliplatin-Induced Neuropathic Pain
por: Lee, Ji Hwan, et al.
Publicado: (2021)

Genetic and biochemical changes of the serotonergic system in migraine pathobiology
por: Gasparini, Claudia Francesca, et al.
Publicado: (2017)

Editorial: Brain serotonergic system
por: Mouradian, Gary C., et al.
Publicado: (2023)

Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction
por: Pehrson, Alan L., et al.
Publicado: (2013)

Serotonergic Neuroplasticity in Alcohol Addiction
por: Belmer, Arnauld, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_d3l29e9qvd06hifbrbf5s2ap0s